INCY Incyte Corporation
$116.60▲ +2.90%
Healthcare
Other
Volume 2.23M
Avg Volume (10D) 1.75M
Key Metrics & Fundamentals
Market Cap
$23.63B
P/E Ratio
14.9
Div Yield
0.00%
52W Range
84.02 - 132.60
% vs 50 MA
-3.63%
% vs 200 MA
8.09%
RSI-14
50.2
MACD Histogram
+0.6500
Beta (1Y vs SPY)
0.37
Free Cash Flow
$495.25M
Gross Rev
$1.67B
Gross Profit
$1.57B
EBITDA
$771.27M
COGS
$105.00M
Operating Exp
$868.65M
Operating Income
$700.39M
EBIT
$700.39M
Pretax Income
$751.51M
Net Income
$585.61M
EPS (Diluted)
2.81
Price & Volume History
Loading chart…
Recent News
Adagene Announces Dosing of First Patient in Phase 1 Study of Muzastotug in Combination with Incyte’s INCA33890 in Patients with Microsatellite Stable Colorectal Cancer
GlobeNewswire · Oct 28, 2026 7:00 AM ET
The $1.5 Billion Question Facing Tempus AI Ahead of Nov. 2 Earnings
24/7 Wall St. · Oct 27, 2026 9:28 AM ET
Incyte Highlights Promising Early Data for ’890 and ’734 in GI Cancers
MarketBeat · Oct 26, 2026 10:02 PM ET
Petosemtamab Trial Results May Change The Case For Genmab Stock
Simply Wall St. · Oct 26, 2026 7:23 PM ET
Genmab's Encouraging Oncology Data Boosts Investor Optimism
Benzinga · Oct 26, 2026 11:08 AM ET
JAK Inhibitors Market to Register Notable Growth During the Forecast Period (2026-2036) Through Expanding Clinical and Commercial Landscape | DelveInsight
PR Newswire · Oct 26, 2026 10:31 AM ET
Incyte & Genmab Collaborate to Develop a New Colorectal Cancer Therapy
Zacks · Oct 26, 2026 10:25 AM ET
Incyte Highlights New Data Advancing its Gastrointestinal Cancer Portfolio at ESMO 2026
Business Wire · Oct 26, 2026 9:45 AM ET
Syndax Pharmaceuticals (SNDX) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
Zacks · Oct 26, 2026 9:00 AM ET
Can Incyte Stock Hit $170?
Trefis · Oct 26, 2026 6:13 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See INCY's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.